The Effectiveness of Immunotherapy Types
In RCCA offices all throughout New Jersey, Maryland and Connecticut, doctors are using immunotherapy to treat patients with cancer. In
HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
We’re here for you. Call us at 844-346-7222 or
In RCCA offices all throughout New Jersey, Maryland and Connecticut, doctors are using immunotherapy to treat patients with cancer. In
At RCCA, radiation therapy is one of the most common methods of treating cancer. It employs high-energy waves to target
After a patient’s cancer is cured, they still need to continue seeing their doctor. Follow-up care is extremely important to
For many types of cancer, surgery is one of the main forms of treatment. Doctors hope to go in and
Just like blue eyes and heart disease might run in your family, cancer can, too. However, only about 5- 10%
If you are currently receiving treatment for cancer, a clinical trial may benefit you in more ways than one. While
Deciding whether or not to participate in a cancer clinical trial is a major healthcare decision. If you qualify, and
The exact cause of prostate cancer is unknown. But, according to the American Cancer Society (ACS), we do know that
The more we know about prostate cancer, the better we can treat it. That’s why doctors at Regional Cancer Care
For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.